Caleres vs Crocs
CAL and CROX side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CAL and CROX compare
Crocs is the larger company, worth 16 times as much as Caleres ($7.3B against $464M).
On earnings, Caleres is cheaper: it trades at 9.0× trailing earnings, against 11.9× for Crocs.
Caleres grew revenue faster over the last twelve months (7.3% versus 0.70% for Crocs).
Crocs keeps more of each dollar of sales as profit, with a net margin of 16.2% compared with 1.8% at Caleres.
Caleres pays a dividend yielding 2.1%; Crocs does not pay one.
Caleres scores higher on the StockData Score (18 against 14 for Crocs), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CAL | CROX |
|---|---|---|
| Size and price | ||
| Market cap | $464M | $7.3B |
| Share price | $13.45 | $159.98 |
| Change, 1 year | 20.7% | 116% |
| Change, 5 years | −49.0% | −8.8% |
| Beta (5Y) | 1.20 | 1.25 |
| Employees | 10K | 8,010 |
| StockData Score | ||
| Total score | 18 (better) | 14 |
| Valuation score | 5 (better) | 4 |
| Growth score | 2 | 2 |
| Performance score | 2 | 4 (better) |
| Health score | 5 (better) | 4 |
| Dividend score | 4 (better) | 0 |
| Valuation | ||
| P/E | 9.0× (better) | 11.9× |
| P/S | 0.2× (better) | 1.8× |
| P/B | 0.7× (better) | 5.4× |
| EV/EBITDA | 4.8× (better) | 8.4× |
| P/FCF | 6.9× (better) | 9.7× |
| FCF yield | 14.5% (better) | 10.3% |
| Fair value | $23.51 | $212.63 |
| Margin of safety | 42.8% (better) | 24.8% |
| Growth | ||
| Revenue growth (TTM) | 7.3% (better) | 0.70% |
| Revenue growth, 5Y average | 5.4% | 23.9% (better) |
| Net income growth (TTM) | −12.4% | 264% (better) |
| EPS growth (TTM) | −14.9% | 337% (better) |
| Profitability | ||
| Gross margin | 46.2% | 59.4% (better) |
| Operating margin | 3.1% | 22.6% (better) |
| Net margin | 1.8% | 16.2% (better) |
| FCF margin | 2.4% | 18.4% (better) |
| Return on equity | 8.2% | 49.1% (better) |
| Return on invested capital | 11.7% | 29.0% (better) |
| Financial health | ||
| Debt / equity | 0.00 | 0.96 (better) |
| Net debt / EBITDA | – | 1.12 |
| Interest coverage | – | 11.5× |
| Current ratio | 1.11 | 1.44 (better) |
| Altman Z-score | 2.04 | 4.58 (better) |
| Piotroski F-score | 4 | 4 |
| Dividends and buybacks | ||
| Dividend yield | 2.1% | – |
| Payout ratio | 18.0% | – |
| Years of dividend growth | 0 | – |
| Dividend growth, 5Y average | 0.00% | – |
| Buyback yield | 1.2% | 9.4% (better) |
| Shareholder yield | 3.3% | 9.4% (better) |
| Ownership | ||
| Held by institutions | 86.5% | 106% |
| Held by insiders | 5.1% | 5.1% |
| Insider net buying, 12 months | −$168K (better) | −$22.4M |
| Superinvestors holding | – | 5 |
| Short interest, % of float | 11.0% | 10.0% |
Go deeper
- CAL stock overview
- CAL income statement
- CAL valuation and score
- CROX stock overview
- CROX income statement
- CROX valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.